Biotechnology - Global

Filter

Current filters:

Global

Popular Filters

1 to 25 of 91 results

AC Immune out-licenses anti-Tau vaccine to Janssen in up to $509 million deal

12-01-2015

Switzerland’s biopharma company AC Immune has entered into a worldwide exclusive license agreement…

AC ImmuneBiotechnologyGlobalJanssen Research & DevelopmentJohnson & JohnsonLicensingNeurological

Egalet buys in two innovative approved pain products, Oxaydo and Sprix

09-01-2015

US biotech firm Egalet Corp has in-licensing two innovative approved pain products transforming Egalet…

Acura PharmaceuticalsBiotechnologyDaiichi SankyoEgalet CorpGlobalLicensingLuitpold PharmaNeurologicalOxaydoSPRIX

Biotech industry shatters key fundraising records in 2014

08-01-2015

The biotech industry shattered records for venture investment, IPOs (initial public offerings) and M&A…

BiotechnologyFinancialGlobalLicensing

Vectura links with Janssen on asthma/COPD drug development

Vectura links with Janssen on asthma/COPD drug development

06-01-2015

UK inhaled therapies developer Vectura Group has entered into a global development and licence agreement…

BiotechnologyGlobalJanssen BiotechJohnson & JohnsonLicensingResearchRespiratory and PulmonaryVectura

Janssen partners with MacroGenics in up to $625 million deal

Janssen partners with MacroGenics in up to $625 million deal

23-12-2014

Shares of US biotech firm MacroGenics rocketed 11.7% to a 10-month high of $38.58 yesterday, on the news…

BiotechnologyGlobalJanssen BiotechJohnson & JohnsonLicensingMacroGenicsMergers & AcquisitionsMGD011Oncology

UPDATE: Lilly rekindles deal with Adocia to develop ultra rapid insulin

UPDATE: Lilly rekindles deal with Adocia to develop ultra rapid insulin

19-12-2014

US pharma major Eli Lilly and French biotech firm Adocia have entered into a worldwide licensing collaboration…

AdociaBioChaperone LisproBiotechnologyDiabetesEli LillyGlobalLicensing

Calithera gains exclusive, global license to Mars Symbioscience's arginase inhibitors

09-12-2014

Calithera Biosciences has signed an exclusive global license agreement with Mars Symbioscience, a division…

BiotechnologyCalithera BiosciencesGlobalLicensingMars SymbioscienceOncology

Array BioPharma to regain global rights to binimetinib from Novartis

04-12-2014

Shares of US biotech firm Array BioPharma leapt 22.8% to $4.80 in after-hours trading on Wednesday, after…

Array BioPharmabinimetinibBiotechnologyGlobalLicensingNovartisOncology

Merck gains rights to NewLink Genetics investigational Ebola vaccine

24-11-2014

US pharma giant Merck & Co has entered into an exclusive worldwide license agreement to research, develop,…

Anti-viralsBiotechnologyGlobalLicensingMerck & CoNewLink GeneticsResearchrVSV-EBOYTropical diseases

Geron in up to $935 million deal with Janssen for imetelstat

Geron in up to $935 million deal with Janssen for imetelstat

14-11-2014

Geron Corp has entered into an exclusive worldwide license and collaboration agreement with Janssen Biotech,…

BiotechnologyGeron CorpGlobalHematologyimetelstatJanssen BiotechJohnson & JohnsonLicensingOncology

NewLink Genetics out-licenses NLG919 to Genentech

NewLink Genetics out-licenses NLG919 to Genentech

20-10-2014

US biotech firm NewLink Genetics saw its share price rocket 21.2% in morning trading today, after it…

BiotechnologyGenentechGlobalLicensingNewLink GeneticsNLG919OncologyRoche

Aduro expands deal with Janssen to lung cancer; worth up to $817 million

Aduro expands deal with Janssen to lung cancer; worth up to $817 million

17-10-2014

Privately-held US cancer immunotherapy developer Aduro BioTech has entered into its second agreement…

Aduro BioTechBiotechnologyGlobalJanssen BiotechJohnson & JohnsonLicensingOncologyResearch

Supply chain pressure can pose serious risk to pharma, experts argue

Supply chain pressure can pose serious risk to pharma, experts argue

16-10-2014

CPhI Worldwide, part of UBM Live’s Pharmaceutical Portfolio, has released the final part of its 2014…

BiotechnologyCPhI WorldwideGlobalPharmaceuticalResearch

Biosimilars set to revolutionize global drug development industry, says report

Biosimilars set to revolutionize global drug development industry, says report

30-09-2014

Intellectual Property and Science business of Thomson Reuters today announced the release of Biosimilars:…

BiosimilarsBiotechnologyGlobalMarkets & MarketingResearch

Boehringer Ingelheim and CureVac link on lung cancer immunotherapy

Boehringer Ingelheim and CureVac link on lung cancer immunotherapy

21-09-2014

Family-owned German drug major Boehringer Ingelheim and German clinical-stage biotech company CureVac…

BiotechnologyBoehringer IngelheimCureVacCV9202GlobalLicensingOncology

Denovo Biopharma acquires Lilly’s enzastaurin for development as a personalized medicine

Denovo Biopharma acquires Lilly’s enzastaurin for development as a personalized medicine

17-09-2014

Privately-held San Diego, USA-based biotech firm Denovo Biopharma has acquired enzastaurin, a late-stage…

BiotechnologyDenovo BiopharmaEli LillyenzastaurinGlobalLicensingOncology

NeuroVive in $150 million deal with OnCore BioPharma for hep B candidate NVP018

12-09-2014

Swedish mitochondrial medicine firm NeuroVive Pharmaceutical has signed an exclusive global out-licensing…

Anti-viralsBiotechnologyGlobalLicensingNeuroVive PharmaceuticalNVP018OnCore BioPharma

Bristol-Myers returns rights to clazakizumab to Alder BioPharma

Bristol-Myers returns rights to clazakizumab to Alder BioPharma

03-09-2014

USA-based drug developer Alder BioPharmaceuticals says it has regained the worldwide rights to clazakizumab,…

Alder BiopharmaceuticalsAnti-Arthritics/RheumaticsBiotechnologyBristol-Myers SquibbclazakizumabGlobalInflammatory diseasesLicensing

Global regenerative medicine market expected to reach $67 billion by 2020

Global regenerative medicine market expected to reach $67 billion by 2020

15-07-2014

The global regenerative medicine market will reach $67.6 billion by 2020, up from $16.4 billion in 2013…

BiotechnologyGlobalImmunologicalsMarkets & MarketingRegenerative medicineResearchStem cells

inVentiv and ACRES partner to create a global research platform for clinical trials

inVentiv and ACRES partner to create a global research platform for clinical trials

11-07-2014

Two bodies are partnering to fast-track the development of a global system to support responsible conduct…

BiotechnologyClinical researchDrug developmentGlobalGreg KoskiinVentive HealthPharmaceuticalResearch

ICBA adopts antimicrobial resistance as an inaugural priority, proposed by BIA

ICBA adopts antimicrobial resistance as an inaugural priority, proposed by BIA

27-06-2014

At the inaugural meeting of the newly formed International Council of Biotech Associations (ICBA) which…

Antibiotics and Infectious diseasesBiotechnologyGlobalHealthcareResearch

Global biotechnology industry needs new paradigm for drug R&D

Global biotechnology industry needs new paradigm for drug R&D

24-06-2014

The global biotechnology industry rebounded strongly in 2013, with public companies achieving double-digit…

BiotechnologyFinancialGlobalResearch

1 to 25 of 91 results

Back to top